국가: 영국
언어: 영어
출처: MHRA (Medicines & Healthcare Products Regulatory Agency)
Citalopram hydrobromide
Lundbeck Ltd
N06AB04
Citalopram hydrobromide
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030300; GTIN: 5702157106301
PACKAGE LEAFLET: INFORMATION FOR THE USER CIPRAMIL ® 10 MG FILM-COATED TABLETS CIPRAMIL ® 20 MG FILM-COATED TABLETS CIPRAMIL ® 40 MG FILM-COATED TABLETS citalopram (as hydrobromide) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to you doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. WHAT CIPRAMIL IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CIPRAMIL 3. HOW TO TAKE CIPRAMIL 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE CIPRAMIL 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT CIPRAMIL IS AND WHAT IT IS USED FOR HOW DOES CIPRAMIL WORK? Cipramil is a Selective Serotonin Reuptake Inhibitor (SSRI) and belongs to a group of medicines known as antidepressants. These medicines help to correct certain chemical imbalances in the brain that are causing the symptoms of your illness. WHAT IS CIPRAMIL USED FOR? Cipramil contains citalopram and is used for the treatment of depression and, when you feel better, to help prevent these symptoms recurring. Cipramil is also used for long-term treatment to prevent the occurrence of new episodes of depression if you have recurrent depression. Cipramil is also beneficial in relieving symptoms if you tend to suffer from panic attacks. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CIPRAMIL DO NOT TAKE CIPRAMIL • if you are allergic to citalopram or to any of the other ingredients of this medicine (listed in section 6). Consult your doctor if you think you might be. • at the same time as taking medication known as monoamine oxidase inhibitors (MAOIs). MAOIs include medicines such as phenelzine, ip 전체 문서 읽기
OBJECT 1 CIPRAMIL TABLETS Summary of Product Characteristics Updated 26-Jan-2017 | Lundbeck Limited 1. Name of the medicinal product Cipramil ® 10 mg film-coated tablets Citalopram 10 mg film-coated tablets Cipramil ® 20 mg film-coated tablets Citalopram 20 mg film-coated tablets Cipramil ® 40 mg film-coated tablets Citalopram 40 mg film-coated tablets 2. Qualitative and quantitative composition 10 mg tablet: Each tablet contains 10 mg citalopram (as 12.49 mg citalopram hydrobromide). 20 mg tablet: Each tablet contains 20 mg citalopram (as 24.98 mg citalopram hydrobromide). 40 mg tablet: Each tablet contains 40 mg citalopram (as 49.96 mg citalopram hydrobromide). Excipients with known effect: Lactose For the full list of excipients, see section 6.1. 3. Pharmaceutical form Film-coated tablet 10 mg tablet: White, round, film-coated tablet marked CL on one side. 20 mg tablet: White, oval, scored, film-coated tablet marked C and N symmetrically around the score. The tablet can be divided into equal doses. 40 mg tablet: White, oval, scored, film-coated tablet marked C and R symmetrically around the score. The tablet can be divided into equal doses. 4. Clinical particulars 4.1 Therapeutic indications Treatment of depressive illness in the initial phase and as maintenance against potential relapse/recurrence. Cipramil/Citalopram is also indicated in the treatment of panic disorder with or without agoraphobia. 4.2 Posology and method of administration POSOLOGY MAJOR DEPRESSIVE EPISODES Adults: Citalopram should be administered as a single oral dose of 20 mg daily. Dependent on individual patient response, the dose may be increased to a maximum of 40 mg daily. In general, improvement in patients starts after one week, but may only become evident from the second week of therapy. As with all antidepressant medicinal products, dosage should be reviewed and adjusted, if necessary, within 3 to 4 weeks of initiation of therapy and thereafter as judged clinically appropriate. Although there may be an incre 전체 문서 읽기